Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Helicobacter pylori Adapts to Chronic Infection and Gastric Disease via pH-Responsive BabA-Mediated Adherence.

Bugaytsova JA, Björnham O, Chernov YA, Gideonsson P, Henriksson S, Mendez M, Sjöström R, Mahdavi J, Shevtsova A, Ilver D, Moonens K, Quintana-Hayashi MP, Moskalenko R, Aisenbrey C, Bylund G, Schmidt A, Åberg A, Brännström K, Königer V, Vikström S, Rakhimova L, Hofer A, Ögren J, Liu H, Goldman MD, Whitmire JM, Ådén J, Younson J, Kelly CG, Gilman RH, Chowdhury A, Mukhopadhyay AK, Nair GB, Papadakos KS, Martinez-Gonzalez B, Sgouras DN, Engstrand L, Unemo M, Danielsson D, Suerbaum S, Oscarson S, Morozova-Roche LA, Olofsson A, Gröbner G, Holgersson J, Esberg A, Strömberg N, Landström M, Eldridge AM, Chromy BA, Hansen LM, Solnick JV, Lindén SK, Haas R, Dubois A, Merrell DS, Schedin S, Remaut H, Arnqvist A, Berg DE, Borén T.

Cell Host Microbe. 2017 Mar 8;21(3):376-389. doi: 10.1016/j.chom.2017.02.013.

2.

Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles.

Coleman MA, Cappuccio JA, Blanchette CD, Gao T, Arroyo ES, Hinz AK, Bourguet FA, Segelke B, Hoeprich PD, Huser T, Laurence TA, Motin VL, Chromy BA.

PLoS One. 2016 Mar 25;11(3):e0150166. doi: 10.1371/journal.pone.0150166. eCollection 2016.

3.

High abundant protein removal from rodent blood for biomarker discovery.

Haudenschild DR, Eldridge A, Lein PJ, Chromy BA.

Biochem Biophys Res Commun. 2014 Dec 5;455(1-2):84-9.

4.

Microbial profiling of combat wound infection through detection microarray and next-generation sequencing.

Be NA, Allen JE, Brown TS, Gardner SN, McLoughlin KS, Forsberg JA, Kirkup BC, Chromy BA, Luciw PA, Elster EA, Jaing CJ.

J Clin Microbiol. 2014 Jul;52(7):2583-94. doi: 10.1128/JCM.00556-14. Epub 2014 May 14.

5.

Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression.

Wang Z, Fan M, Candas D, Zhang TQ, Qin L, Eldridge A, Wachsmann-Hogiu S, Ahmed KM, Chromy BA, Nantajit D, Duru N, He F, Chen M, Finkel T, Weinstein LS, Li JJ.

Dev Cell. 2014 Apr 28;29(2):217-32. doi: 10.1016/j.devcel.2014.03.012. Epub 2014 Apr 17.

6.

Proteomic sample preparation for blast wound characterization.

Chromy BA, Eldridge A, Forsberg JA, Brown TS, Kirkup BC, Elster E, Luciw P.

Proteome Sci. 2014 Feb 14;12(1):10. doi: 10.1186/1477-5956-12-10.

7.

Wound outcome in combat injuries is associated with a unique set of protein biomarkers.

Chromy BA, Eldridge A, Forsberg JA, Brown TS, Kirkup BC, Jaing C, Be NA, Elster E, Luciw PA.

J Transl Med. 2013 Nov 6;11:281. doi: 10.1186/1479-5876-11-281.

8.

HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.

Duru N, Fan M, Candas D, Menaa C, Liu HC, Nantajit D, Wen Y, Xiao K, Eldridge A, Chromy BA, Li S, Spitz DR, Lam KS, Wicha MS, Li JJ.

Clin Cancer Res. 2012 Dec 15;18(24):6634-47. doi: 10.1158/1078-0432.CCR-12-1436. Epub 2012 Oct 22.

9.

Manganese superoxide dismutase interacts with a large scale of cellular and mitochondrial proteins in low-dose radiation-induced adaptive radioprotection.

Eldridge A, Fan M, Woloschak G, Grdina DJ, Chromy BA, Li JJ.

Free Radic Biol Med. 2012 Nov 15;53(10):1838-47. doi: 10.1016/j.freeradbiomed.2012.08.589. Epub 2012 Sep 6.

10.

Repurposing screens identify rifamycins as potential broad-spectrum therapy for multidrug-resistant Acinetobacter baumannii and select agent microorganisms.

Chromy BA, Elsheikh M, Christensen TL, Livingston D, Petersen K, Bearinger JP, Hoeprich PD.

Future Microbiol. 2012 Aug;7(8):1011-20. doi: 10.2217/fmb.12.75.

PMID:
22913359
11.

Cluster analysis of host cytokine responses to biodefense pathogens in a whole blood ex vivo exposure model (WEEM).

Chromy BA, Fodor IK, Montgomery NK, Luciw PA, McCutchen-Maloney SL.

BMC Microbiol. 2012 May 20;12:79. doi: 10.1186/1471-2180-12-79.

12.

Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague.

Lin JS, Szaba FM, Kummer LW, Chromy BA, Smiley ST.

J Immunol. 2011 Jul 15;187(2):897-904. doi: 10.4049/jimmunol.1100174. Epub 2011 Jun 8.

13.

Isolation, characterization, and stability of discretely-sized nanolipoprotein particles assembled with apolipophorin-III.

Fischer NO, Blanchette CD, Segelke BW, Corzett M, Chromy BA, Kuhn EA, Bench G, Hoeprich PD.

PLoS One. 2010 Jul 19;5(7):e11643. doi: 10.1371/journal.pone.0011643.

14.

Efficient maximum likelihood estimator fitting of histograms.

Laurence TA, Chromy BA.

Nat Methods. 2010 May;7(5):338-9. doi: 10.1038/nmeth0510-338. No abstract available.

PMID:
20431544
15.

Statistical analysis of variation in the human plasma proteome.

Corzett TH, Fodor IK, Choi MW, Walsworth VL, Turteltaub KW, McCutchen-Maloney SL, Chromy BA.

J Biomed Biotechnol. 2010;2010:258494. doi: 10.1155/2010/258494. Epub 2010 Jan 14.

16.

Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particles.

Blanchette CD, Segelke BW, Fischer N, Corzett MH, Kuhn EA, Cappuccio JA, Benner WH, Coleman MA, Chromy BA, Bench G, Hoeprich PD, Sulchek TA.

Int J Mol Sci. 2009 Jul 2;10(7):2958-71. doi: 10.3390/ijms10072958.

17.

Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2.

Tükel C, Wilson RP, Nishimori JH, Pezeshki M, Chromy BA, Bäumler AJ.

Cell Host Microbe. 2009 Jul 23;6(1):45-53. doi: 10.1016/j.chom.2009.05.020.

18.

Hydrogen production by a hyperthermophilic membrane-bound hydrogenase in water-soluble nanolipoprotein particles.

Baker SE, Hopkins RC, Blanchette CD, Walsworth VL, Sumbad R, Fischer NO, Kuhn EA, Coleman M, Chromy BA, Létant SE, Hoeprich PD, Adams MW, Henderson PT.

J Am Chem Soc. 2009 Jun 10;131(22):7508-9. doi: 10.1021/ja809251f.

PMID:
19449869
19.

Immobilization of His-tagged proteins on nickel-chelating nanolipoprotein particles.

Fischer NO, Blanchette CD, Chromy BA, Kuhn EA, Segelke BW, Corzett M, Bench G, Mason PW, Hoeprich PD.

Bioconjug Chem. 2009 Mar 18;20(3):460-5. doi: 10.1021/bc8003155.

PMID:
19239247
20.

Atomic force microscopy differentiates discrete size distributions between membrane protein containing and empty nanolipoprotein particles.

Blanchette CD, Cappuccio JA, Kuhn EA, Segelke BW, Benner WH, Chromy BA, Coleman MA, Bench G, Hoeprich PD, Sulchek TA.

Biochim Biophys Acta. 2009 Mar;1788(3):724-31. doi: 10.1016/j.bbamem.2008.11.019. Epub 2008 Dec 8.

21.

Cell-free expression for nanolipoprotein particles: building a high-throughput membrane protein solubility platform.

Cappuccio JA, Hinz AK, Kuhn EA, Fletcher JE, Arroyo ES, Henderson PT, Blanchette CD, Walsworth VL, Corzett MH, Law RJ, Pesavento JB, Segelke BW, Sulchek TA, Chromy BA, Katzen F, Peterson T, Bench G, Kudlicki W, Hoeprich PD Jr, Coleman MA.

Methods Mol Biol. 2009;498:273-96. doi: 10.1007/978-1-59745-196-3_18.

PMID:
18988032
22.

Cell-free co-expression of functional membrane proteins and apolipoprotein, forming soluble nanolipoprotein particles.

Cappuccio JA, Blanchette CD, Sulchek TA, Arroyo ES, Kralj JM, Hinz AK, Kuhn EA, Chromy BA, Segelke BW, Rothschild KJ, Fletcher JE, Katzen F, Peterson TC, Kudlicki WA, Bench G, Hoeprich PD, Coleman MA.

Mol Cell Proteomics. 2008 Nov;7(11):2246-53. doi: 10.1074/mcp.M800191-MCP200. Epub 2008 Jul 4.

23.

Insertion of membrane proteins into discoidal membranes using a cell-free protein expression approach.

Katzen F, Fletcher JE, Yang JP, Kang D, Peterson TC, Cappuccio JA, Blanchette CD, Sulchek T, Chromy BA, Hoeprich PD, Coleman MA, Kudlicki W.

J Proteome Res. 2008 Aug;7(8):3535-42. doi: 10.1021/pr800265f. Epub 2008 Jun 17.

PMID:
18557639
24.

Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations.

Blanchette CD, Law R, Benner WH, Pesavento JB, Cappuccio JA, Walsworth V, Kuhn EA, Corzett M, Chromy BA, Segelke BW, Coleman MA, Bench G, Hoeprich PD, Sulchek TA.

J Lipid Res. 2008 Jul;49(7):1420-30. doi: 10.1194/jlr.M700586-JLR200. Epub 2008 Apr 9.

25.

Different apolipoproteins impact nanolipoprotein particle formation.

Chromy BA, Arroyo E, Blanchette CD, Bench G, Benner H, Cappuccio JA, Coleman MA, Henderson PT, Hinz AK, Kuhn EA, Pesavento JB, Segelke BW, Sulchek TA, Tarasow T, Walsworth VL, Hoeprich PD.

J Am Chem Soc. 2007 Nov 21;129(46):14348-54. Epub 2007 Oct 27.

PMID:
17963384
26.

Biomarker candidate identification in Yersinia pestis using organism-wide semiquantitative proteomics.

Hixson KK, Adkins JN, Baker SE, Moore RJ, Chromy BA, Smith RD, McCutchen-Maloney SL, Lipton MS.

J Proteome Res. 2006 Nov;5(11):3008-17.

PMID:
17081052
27.

Statistical analysis of the experimental variation in the proteomic characterization of human plasma by two-dimensional difference gel electrophoresis.

Corzett TH, Fodor IK, Choi MW, Walsworth VL, Chromy BA, Turteltaub KW, McCutchen-Maloney SL.

J Proteome Res. 2006 Oct;5(10):2611-9.

PMID:
17022632
28.

An integrated proteomic workflow for two-dimensional differential gel electrophoresis and robotic spot picking.

Mahnke RC, Corzett TH, McCutchen-Maloney SL, Chromy BA.

J Proteome Res. 2006 Sep;5(9):2093-7.

PMID:
16944920
29.

Proteomic characterization of Yersinia pestis virulence.

Chromy BA, Choi MW, Murphy GA, Gonzales AD, Corzett CH, Chang BC, Fitch JP, McCutchen-Maloney SL.

J Bacteriol. 2005 Dec;187(23):8172-80.

30.

Host-pathogen interactions: a proteomic view.

Zhang CG, Chromy BA, McCutchen-Maloney SL.

Expert Rev Proteomics. 2005 Apr;2(2):187-202. Review.

PMID:
15892564
31.

Subcellular proteomic analysis of host-pathogen interactions using human monocytes exposed to Yersinia pestis and Yersinia pseudotuberculosis.

Zhang CG, Gonzales AD, Choi MW, Chromy BA, Fitch JP, McCutchen-Maloney SL.

Proteomics. 2005 May;5(7):1877-88.

PMID:
15825148
32.

Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins.

Chromy BA, Gonzales AD, Perkins J, Choi MW, Corzett MH, Chang BC, Corzett CH, McCutchen-Maloney SL.

J Proteome Res. 2004 Nov-Dec;3(6):1120-7.

PMID:
15595720
33.

Proteomic characterization of host response to Yersinia pestis and near neighbors.

Chromy BA, Perkins J, Heidbrink JL, Gonzales AD, Murphy GA, Fitch JP, McCutchen-Maloney SL.

Biochem Biophys Res Commun. 2004 Jul 23;320(2):474-9.

PMID:
15219853
34.

Serum protein profile alterations in hemodialysis patients.

Langlois RG, Trebes JE, Dalmasso EA, Ying Y, Davies RW, Curzi MP, Colston BW Jr, Turteltaub KW, Perkins J, Chromy BA, Choi MW, Murphy GA, Fitch JP, McCutchen-Maloney SL.

Am J Nephrol. 2004 Mar-Apr;24(2):268-74. Epub 2004 Mar 19.

PMID:
15031630
35.

Self-assembly of Abeta(1-42) into globular neurotoxins.

Chromy BA, Nowak RJ, Lambert MP, Viola KL, Chang L, Velasco PT, Jones BW, Fernandez SJ, Lacor PN, Horowitz P, Finch CE, Krafft GA, Klein WL.

Biochemistry. 2003 Nov 11;42(44):12749-60.

PMID:
14596589
36.

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.

Lambert MP, Viola KL, Chromy BA, Chang L, Morgan TE, Yu J, Venton DL, Krafft GA, Finch CE, Klein WL.

J Neurochem. 2001 Nov;79(3):595-605.

37.
38.

Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.

Hu J, Akama KT, Krafft GA, Chromy BA, Van Eldik LJ.

Brain Res. 1998 Mar 2;785(2):195-206.

PMID:
9518610
39.

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL.

Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53.

40.

Induction of the serotonin1A receptor in neuronal cells during prolonged stress and degeneration.

Singh JK, Chromy BA, Boyers MJ, Dawson G, Banerjee P.

J Neurochem. 1996 Jun;66(6):2361-72.

PMID:
8632158
41.

Stable expression and heterologous coupling of the kappa opioid receptor in cell lines of neural and nonneural origin.

Banerjee P, Chromy BA, Berry-Kravis E, Hammond D, Singh JK, Dawson G.

Life Sci. 1996;58(15):1277-84.

PMID:
8614281

Supplemental Content

Loading ...
Support Center